Mom takes on Vertex CEO about pricey Cystic Fibrosis Treatment Drugs
Imogene
October 26, 2016
In October, Oklahoma-based journalist and mom Juliana Keeping traveled to Boston with her son to confront Jeffrey Leiden, the CEO of Vertex Pharmaceuticals. Keeping’s son, Eli, has cystic fibrosis, and she’s not happy that Vertex’s two-drug combo, Orkambi, costs $259,000 a year. So Keeping, who gathered more than 124,700 signatures on Change.org, presented four members of Leiden’s team with the petition, which reads simply, “Stop price gouging our charity-funded drugs.”
